Siegfried, J. M., Gubish, C. T., Rothstein, M. E., Henry, C., & Stabile, L. P. (2012). Combining the Multi-Targeted Tyrosine Kinase Inhibitor Vandetanib with the Anti-Estrogen Fulvestrant Enhances its Anti-tumor Effect in Non-Small Cell Lung Cancer.

Siegfried, Jill M., Christopher T. Gubish, Mary E. Rothstein, Cassandra Henry, e Laura P. Stabile. Combining the Multi-Targeted Tyrosine Kinase Inhibitor Vandetanib With the Anti-Estrogen Fulvestrant Enhances Its Anti-tumor Effect in Non-Small Cell Lung Cancer. 2012.

Siegfried, Jill M., et al. Combining the Multi-Targeted Tyrosine Kinase Inhibitor Vandetanib With the Anti-Estrogen Fulvestrant Enhances Its Anti-tumor Effect in Non-Small Cell Lung Cancer. 2012.